Literature DB >> 20230923

Phosphoproteomic analysis of primary human multiple myeloma cells.

Feng Ge1, Chuan-Le Xiao, Xing-Feng Yin, Chun-Hua Lu, Hui-Lan Zeng, Qing-Yu He.   

Abstract

Multiple myeloma (MM) is a malignant disorder of differentiated B cells. Clonal expansion of the tumor results in the excessive production of monoclonal immunoglobulin (Ig) which is a diagnostic feature of this disease. Previous investigations have demonstrated the alteration of the ERK, jun kinase, STAT, and AKT kinase signaling cascades in MM cells, suggesting that deregulated phosphorylation may contribute to MM pathogenesis. However, systematic analysis of the phosphoproteome in MM cells has not been reported. Here, we described a large-scale phosphorylation analysis of primary MM cells. Using a separation strategy involving immunomagnetic bead-positive selection of MM cells, preparative SDS-PAGE for prefractionation, in-gel digestion with trypsin, and titanium dioxide enrichment of phosphopeptides, followed by LC-MS/MS analysis employing a hybrid LTQ-Orbitrap mass spectrometer, we were able to catalog a substantial portion of the phosphoproteins present in primary MM cells. This analysis led to the identification of 530 phosphorylation sites from 325 unique phosphopeptides corresponding to 260 proteins at false positive rate (FPR) of 1.3%. This dataset provides an important resource for future studies on phosphorylation and carcinogenesis analysis of multiple myeloma. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20230923     DOI: 10.1016/j.jprot.2010.03.004

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  15 in total

1.  Phosphoproteomic analysis of protein phosphorylation networks in Tetrahymena thermophila, a model single-celled organism.

Authors:  Miao Tian; Xiulan Chen; Qian Xiong; Jie Xiong; Chuanle Xiao; Feng Ge; Fuquan Yang; Wei Miao
Journal:  Mol Cell Proteomics       Date:  2013-11-07       Impact factor: 5.911

Review 2.  Diseases of the Nucleoskeleton.

Authors:  James M Holaska
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

Review 3.  Proteomic analysis in multiple myeloma research.

Authors:  Jana Cumova; Anna Potacova; Zbynek Zdrahal; Roman Hajek
Journal:  Mol Biotechnol       Date:  2011-01       Impact factor: 2.695

4.  Metabolic, Anti-apoptotic and Immune Evasion Strategies of Primary Human Myeloma Cells Indicate Adaptations to Hypoxia.

Authors:  Lukas Janker; Rupert L Mayer; Andrea Bileck; Dominique Kreutz; Johanna C Mader; Kirsten Utpatel; Daniel Heudobler; Hermine Agis; Christopher Gerner; Astrid Slany
Journal:  Mol Cell Proteomics       Date:  2019-02-21       Impact factor: 5.911

5.  Plasmodium vivax inhibits erythroid cell growth through altered phosphorylation of the cytoskeletal protein ezrin.

Authors:  Tasanee Panichakul; Saranyoo Ponnikorn; Sittiruk Roytrakul; Atchara Paemanee; Suthathip Kittisenachai; Suradej Hongeng; Rachanee Udomsangpetch
Journal:  Malar J       Date:  2015-03-31       Impact factor: 2.979

6.  Proteomics-inspired precision medicine for treating and understanding multiple myeloma.

Authors:  Matthew Ho; Giada Bianchi; Kenneth C Anderson
Journal:  Expert Rev Precis Med Drug Dev       Date:  2020-02-24

Review 7.  Emerin in health and disease.

Authors:  Adam J Koch; James M Holaska
Journal:  Semin Cell Dev Biol       Date:  2013-12-21       Impact factor: 7.727

Review 8.  Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond.

Authors:  Ziyou Cui; Sarah B Scruggs; Jennifer E Gilda; Peipei Ping; Aldrin V Gomes
Journal:  J Mol Cell Cardiol       Date:  2013-10-17       Impact factor: 5.000

9.  Phosphoproteomic analysis of apoptotic hematopoietic stem cells from hemoglobin E/β-thalassemia.

Authors:  Saranyoo Ponnikorn; Tasanee Panichakul; Kitima Sresanga; Chokdee Wongborisuth; Sittiruk Roytrakul; Suradej Hongeng; Sumalee Tungpradabkul
Journal:  J Transl Med       Date:  2011-06-25       Impact factor: 5.531

10.  Characterization of a TiO₂ enrichment method for label-free quantitative phosphoproteomics.

Authors:  Alex Montoya; Luisa Beltran; Pedro Casado; Juan-Carlos Rodríguez-Prados; Pedro R Cutillas
Journal:  Methods       Date:  2011-02-18       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.